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Abstract
Excessive intake of dietary fat is known to be a contributing factor in the development of obesity. In this study, we
determined the dose-dependent effects of dietary fat on the development of this metabolic condition with a focus on
changes in gene expression in the small intestine. C57BL/6J mice were fed diets with either 10, 20, 30 or 45 energy% (E%)
derived from fat for four weeks (n = 10 mice/diet). We found a significant higher weight gain in mice fed the 30E% and 45E%
fat diet compared to mice on the control diet. These data indicate that the main shift towards an obese phenotype lies
between a 20E% and 30E% dietary fat intake. Analysis of differential gene expression in the small intestine showed a fat-
dose dependent gradient in differentially expressed genes, with the highest numbers in mice fed the 45E% fat diet. The
main shift in fat-induced differential gene expression was found between the 30E% and 45E% fat diet. Furthermore,
approximately 70% of the differentially expressed genes were changed in a fat-dose dependent manner. Many of these
genes were involved in lipid metabolism-related processes and were already differentially expressed on a 30E% fat diet.
Taken together, we conclude that up to 20E% of dietary fat, the small intestine has an effective ‘buffer capacity’ for fat
handling. From 30E% of dietary fat, a switch towards an obese phenotype is triggered. We further speculate that especially
fat-dose dependently changed lipid metabolism-related genes are involved in development of obesity.
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Introduction
Excessive intake of dietary fat is known to be a substantial
contributing factor to the development of obesity in Western
society. Many mouse studies have been performed to study the
effect of dietary fat on the etiology of obesity, a major risk factor of
the metabolic syndrome [1,2,3,4]. For this, most studies compared
the effects of two diets with a low versus high fat-content.
Moreover, these differences in fat-dose are mostly quite extreme,
such as 5–10 energy percent (E%) fat versus 30–45E% fat or even
higher. Dose-dependent effects of dietary fat on the development
of obesity are rarely investigated.
Whereas organs, such as liver, muscle and white adipose tissue
are frequently studied in relation to dietary fat-induced obesity and
insulin resistance, the intestine is mostly neglected [5,6,7,8].
However, there is growing evidence that the small intestine as an
endocrine organ also contributes to the etiology of the metabolic
syndrome. Several studies have previously shown that dietary fat-
induced changes in intestinal gene expression might be related to
obesity [9,10]. In these studies, the effects of low fat (5–10E%) and
high fat (30–45E%) diets were compared, but dose-dependent
effects of dietary fat have never been studied. Therefore in this
study, we used diets with 10E% (control diet), 20E%, 30E% and
45E% of dietary fat to determine dose-dependent fat-effects on
development of obesity in C57Bl/6J mice and determined dif-
ferential gene expression in the proximal, middle and distal part of
the small intestine of these mice.
Materials and Methods
Ethics statement
The institutional and national guidelines for the care and use of
animals were followed and the experiment was approved by the
Local Committee for Care and Use of Laboratory Animals at
Wageningen University.
Animals and diets
The study described here is part of the Nugo Proof of Principle
study package as described by Baccini et al. [11].
Male C57BL/6J mice were obtained from Charles River
(Maastricht, The Netherlands) at three weeks of age. The mice
were housed in pairs. At twelve weeks of age, all mice received
control diet as a run-in for four weeks. After the run-in period mice
were divided in four groups that received 45, 30, 20, or a control
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diet of 10 energy % (10E%) of dietary fat (n = 10 per group). Palm
oil was the main fat source in the diets. The only other variable in
the diets was the amount of corn starch (Table S1). Body weight
and food intake were measured weekly. After four weeks of diet
intervention, mice were fasted for five hours and subsequently
anaesthetized with a mixture of isoflurane (1.5%), nitrous oxide
(70%), and oxygen (30%). Mice were killed by cervical dislocation.
For RNA isolation small intestine was excised, divided in three
equal parts, cut open longitudinally, and washed with PBS. The
mucosa was scraped and snap frozen in liquid nitrogen.
Transcriptomics analysis
Total RNA was extracted from intestinal scrapings with TRIzol
reagent (Invitrogen, Carlsbad, CA), treated with DNase and
purified on columns using the RNeasy Mini Kit (Qiagen, Venlo,
The Netherlands). RNA integrity was checked on an Agilent 2100
Bioanalyzer (Agilent Technologies, Amsterdam, The Netherlands)
with 6000 Nano Chips. RNA was judged as suitable only if
samples showed intact bands of 18S and 28S ribosomal RNA
subunits, displayed no chromosomal peaks or RNA degradation
products, and had a RNA integrity number (RIN) above 8.0.
For each individual mouse (n = 10 per diet group), total RNA
(5 mg) of the proximal, middle and distal part of the small intestine
was labeled using the Affymetrix One-Cycle Target Labelling
Assay kit (Affymetrix, Santa Clara, CA). Each individual labeled
RNA sample (n = 120), was hybridized on a Affymetrix NuGO
mouse array, washed, stained, and scanned on an Affymetrix
GeneChip 3000 7G scanner. The NuGO arrays are custom
designed Affymetrix GeneChip arrays, designed by the European
Nutrigenomics Organisation (NuGO) and manufactured by
Affymetrix. These arrays contain in part common probe sets that
are also present on standard Affymetrix arrays and in part
newly designed probe sets (Gene Expression Omnibus platform
GPL7440).
Packages from the Bioconductor project, integrated in an in-
house developed online management and analysis database for
multiplatform microarray experiments, were used to analyze
scanned arrays [12]. Probesets were redefined according to Dai et
al. using remapped CDF version 11.0.2 based on the Entrez Gene
database [13]. The Nugo Mouse GeneChip arrays target 15,240
unique gene identifiers. GC-robust multi-array (GCRMA) analysis
was used to obtain expression values [14]. Only genes that had an
unlogged intensity above five on at least five arrays were
considered for analysis. The normalization and filtering procedure
was performed separately for each of the three parts of the small
intestine. In each part of the intestine, approximately 11,000 genes
were detected. The Bioconductor R package Linear models for
microarray data (LIMMA) was used to identify differentially
expressed genes, based on the 10 replicate microarrays per diet
group, per part of the small intestine. [15]. Obtained p-values were
corrected for multiple testing using a false discovery rate (FDR)
method [16]. Genes that met the cut-off of FDR q-value,0.05
were considered to be significantly regulated. All microarray data
are MIAME compliant and array data have been submitted to the
Gene Expression Omnibus (accession number GSE26300).
Statistical analysis
Physiological data are reported as the mean 6 the standard
error (SE). The differences between the mean values were tested
for statistical significance by a one-way ANOVA with an
additional Bonferroni post-hoc test (PASW Statistics 17.0 software,
SPSS Inc., Chicago, Illinois, USA). P-values,0.05 are considered
statistically significant.
Results
Food intake and weight gain
To determine dose-dependent effects of dietary fat on
development of obesity, C57Bl/6J mice were fed four diets
containing different amounts of dietary fat, namely 10E%, 20E%,
30E% and 45E% of palm oil, for four weeks. Food intake was not
significantly different between groups, although there was a
slightly increased energy intake as the amount of fat in the diet
increased. In comparison to the 10E% fat diet serving as a
reference, weight gain was not increased significantly on the 20E%
fat diet whereas animals on 30E% and 45E% fat diets displayed
significantly higher weight gains (Figure 1). Therefore, the main
shift towards an obese phenotype occurs with diets of 20E% to
30E% of fat, which is not significantly worsened with higher levels
of dietary fat.
Differential gene expression in the small intestine
In a previous study we have shown that the intestine plays an
important role in the development of dietary fat-induced
metabolic syndrome [10]. A 45E% fat diet intervention induced
clear effects on intestinal gene expression that could be linked to
obesity. As we here observed dose-dependent effects of dietary fat
on development of obesity, we analyzed gene expression changes
in mucosal scrapings of the proximal, middle and distal part of the
small intestine. Differential gene expression was determined for
each part of the small intestine by comparing the gene expression
profiles of mice (n = 10 per diet group) fed the 20E%, 30E% and
45E% fat diets with the reference group (10E% fat diet). We found
a gradient in numbers of differentially expressed genes, with hardly
any changes in tissues of animals on the 20E% fat diet and the
highest number of differentially expressed genes on the 45E% fat
diet (Figure 2A). Remarkably, for the 20E% and 30E% fat diet
groups, changes in gene expression were mainly detected in the
proximal small intestine, whereas on the 45E% fat diet the effect
was most pronounced in the middle part. For all diet groups
hardly any changes in gene expression could be detected in the
distal small intestine. Although the numbers of differentially
expressed genes were much lower in the 20E% and 30E% diet
groups, we found a substantial overlap with genes that were also
differentially expressed on the 45E% fat diet (Figure 2B) and this
occurred in all parts of the small intestine.
Figure 1. Body weight gain and blood glucose levels. Body
weight gain of C57BL/6J mice fed a 10E%, 20E%, 30E% or 45E% fat diet
for four weeks. The data are given as means 6 SE. a, b, c: bars with
superscripts without a common letter differ, p,0.05.
doi:10.1371/journal.pone.0019145.g001
Effect of Fat-Dose on Intestinal Transcriptome
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Next, we determined whether the up- or down-regulation that
we found for the differentially expressed genes was dose-
dependent. Therefore, we selected the genes with a significant
difference in expression level (q-value,0.05) on at least one of the
diets and analyzed dose-dependent changes based on the fold
changes as determined by LIMMA analysis. An example is shown
in figure 3A. Note that for all groups the fold changes were in the
same direction (up- or down-regulation), but in the 20E% and
30E% fat diet groups not all differential expression reached
significance. Remarkably, we found that in general approximately
70% of the total number of differentially expressed genes showed a
dose-dependent fat effect (Figure 3B). Next, we determined in
which biological processes these dose-dependently changed genes
are involved based on their Gene Ontology (GO Biological
Processes). This revealed that many of the genes are involved in
lipid metabolism, cell cycle, immune response and carbohydrate
metabolism, especially in the proximal and middle part of the
small intestine (Figure 4). For lipid metabolism, a substantial
number of genes already showed a significant up- or down-
regulation in the 30E% fat diet group, whereas for the other
biological processes significant changes were mainly restricted to
the 45E% fat diet group. Differentially expressed genes involved in
lipid metabolism in the proximal small intestine were further
analyzed with respect to their predominant cellular localization
(GO Cellular Localization) and classified by their functions within
lipid metabolism (Figure 5). This analysis revealed that most
cholesterol transporters showed a dose-dependent down-regula-
tion (e.g. Abcg5, Abcg8, Abca1 and Npc1l1) and genes playing a role in
fatty acid catabolism, especially ketogenesis and mitochondrial/
peroxisomal fatty acid oxidation, were dose-dependently up-
regulated (e.g Acaa2, Cpt2, Hmgcs2, Acot4/8, Acox2). Moreover,
we found that from all dose-dependently changed genes in the
Figure 2. Differential gene expression along the longitudinal axis of the small intestine. For the proximal, middle and distal part of the
small intestine, the numbers of genes that are differentially expressed on a 20E%, 30E% and 45E% fat diet compared to the control 10E% fat diet are
plotted (A). Venn diagrams display the overlap of differentially expressed genes between the 20E%, 30E% and 45E% fat diets for each part of the
small intestine (B).
doi:10.1371/journal.pone.0019145.g002
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proximal and middle small intestine, about 40% were peroxisome
proliferator-activated receptor alpha (Ppara) target genes, accord-
ing to Bunger et al. [17]. Figure 5, in which Ppara target genes are
depicted in italics, shows that especially fatty acid oxidation in
mitochondria and in peroxisomes are under control of Ppara that
is considered to work as a fat sensor activated by fatty acids. Our
data now indicate that Ppara activation in the intestine occurs in a
dose-dependent manner related to dietary fat intake. For cell cycle,
immune response and carbohydrate metabolism, the gene
expression changes did not direct towards a clear elevation or
repression of these biological processes.
Discussion
In this study, we analyzed the dose-dependent effects of dietary
fat on body weight gain, which is linked to development of diet-
induced obesity. We found that a subtle elevation of dietary fat in
the diet (10 E% to 20E%) had hardly any effect on development of
the obese phenotype. Also on gene expression levels, we found
minimal changes in the small intestine induced by the 20E% fat
diet. This indicates that this subtle elevation of dietary fat has no
substantial effect on the small intestine; the intestine seems to have
a certain ‘buffer-capacity’ that enables the tissue to handle a
limited amount of fat without changing biological processes related
to metabolism, cell cycle and immune response. From 30E% of
dietary fat we observed a significant increase of body weight with
concomitant changes in gene expression in the small intestine.
Genes with changed mRNA levels were predominantly related to
lipid transport (e.g. Fabp2, CD36, ApoC2) and fatty acid catabolism
(e.g. Hmgcs2, Acox2, Acadl) which all represent processes known to
be regulated by Ppara [17]. This implies that on the 30E% fat diet
the small intestine needs to adjust its lipid metabolism-related
processes for proper handling of the overload of dietary fat that
reaches the intestine and that Ppara plays an important regulatory
role in this adaptation. These adjustments in lipid metabolism can
mainly be found in the proximal and middle part of the small
intestine, where fat absorption commonly takes place. The lipid
metabolism-related changes that were already found on the 30E%
Figure 3. Fat-dose dependent regulation of gene expression in the small intestine. By applying specific inclusion criteria (A), fat-dose
dependent regulation of gene expression was determined for the proximal, middle and distal part of the small intestine (B). In brackets, the
percentages of fat-dose dependently changed genes are shown as part of total differentially expressed genes on the 20E%, 30E% and 45E% fat diets
compared to the control 10E% fat diet. FC: fold changes, DD: dose-dependent, non-DD: non-dose-dependent.
doi:10.1371/journal.pone.0019145.g003
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fat diet are even more pronounced on the 45E% fat diet.
Additionally, other lipid metabolism-related genes were highly
affected on the 45E% fat diet. Amongst those are genes that relate
to reduced cholesterol absorption, which was previously suggested
to be related to development of metabolic syndrome [18]. We also
found other biological processes that are substantially affected on
the 45E% fat diet, such as cell cycle and immune response-related
processes. As the gene expression changes related to these
processes are mainly restricted to the 45E% fat diet, these
processes do not seem to directly contribute to the onset of the
obese phenotype. However, they could be important for
remodeling and adjusting immune functions in the small intestine.
The intestinal overload of fat on the 45E% fat diet is also reflected
in the increased numbers of differentially expressed genes in the
middle and even the distal part of the gut. This may be taken as an
indicator that fat digestion and absorption now extents to more
distal parts that also adapts with changes in gene expression.
In summary, intestinal gene expression shows major changes by
increasing the dietary fat content in mouse diets and numerous
genes display a dose-dependent alteration in mRNA levels
depending on dietary fat content. Genes induced by feeding
20E% and 30E% fat diets are predominantly related to lipid
metabolism and especially to those regulated by Ppara. In the
intestine of animals fed 45E% fat, changes in gene expression
Figure 4. Heat map diagrams of fat-dose dependently changed genes, categorized according to their biological function. Fat-dose
dependently changed genes were clustered in a heat map diagram for the proximal and middle part of the small intestine, based on their GO
Biological Processes annotation. Genes involved in lipid metabolism, cell cycle/apoptosis, immune response and carbohydrate metabolism were
highly overrepresented. The heat maps display fold changes of differential gene expression induced by the 20E%, 30E% and 45E% fat diets compared
to the control 10E% fat diet (only genes with fold changes .1.3 or ,21.3 are shown). Red and green indicate (gradual) up- and down-regulation,
respectively, whereas black means no change in gene expression.
doi:10.1371/journal.pone.0019145.g004
Figure 5. Cellular localization and specific lipid metabolism-related function of fat-dose dependently changed genes. Fat-dose
dependently changed genes involved in lipid metabolism (GO Biological Processes) in the proximal part of the small intestine were categorized and
visualized based on their cellular localization (GO Cellular Localization) and the specific lipid-metabolism related processes that occur in these cellular
compartments. The heat maps next to the genes indicate their fat-dose dependent regulation. Red and green indicate (gradual) up- and down-
regulation, respectively, whereas black means no change in gene expression. Ppara target genes are indicated in italics.
doi:10.1371/journal.pone.0019145.g005
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extend more into distal segments of the small intestine indicating
compensatory adaptation to allow more fat to be digested and
absorbed. At the highest fat intake, numerous genes with changed
expression levels can be identified that relate to alterations in cell
cycle and immune functions. From our study we may conclude
that dietary fat itself has a pronounced effect on the intestinal
transcriptome as indicated by dose-dependent changes in gene
expression – mainly in the proximal and middle small intestine –
and that especially alterations in lipid metabolism-related genes
may contribute to obesity development.
Supporting Information
Table S1 Diet composition. * Mineral Mix S10026 contains
the following (g/kg mineral mix): magnesium oxide, 41.9;
magnesium sulfate.7H2O, 257.6; sodium chloride, 259; chromium
KSO4.12H2O, 1.925; cupric carbonate, 1.05; potassium iodate,
0.035; ferric citrate, 21; manganous carbonate, 12.25; sodium
selenite, 0.035; zinc carbonate, 5.6; sodium fluoride, 0.20;
ammonium molybdate.4H2O, 0.30; sucrose, 399.105. * Vitamin
Mix V10001 contains the following (g/kg vitamin mix): retinyl
palmitate, 0.80; cholecalciferol, 1.0; all-rac-a-tocopheryl acetate,
10; menadione sodiumbisulfite, 0.08; biotin (1.0%), 2.0; cyanco-
cobalamin (0.1%), 1.0; folic acid, 0.20; nicotinic acid, 3.0; calcium
pantothenate, 1.6; pyridoxine-HCl, 0.70; riboflavin, 0.60; thiamin-
HCl, 0.60; and sucrose, 978.42.
(DOC)
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